Daniel Steinberg to Myocardial Infarction
This is a "connection" page, showing publications Daniel Steinberg has written about Myocardial Infarction.
Connection Strength
1.231
-
Vulnerable plaque imaging-current techniques. J Cardiovasc Transl Res. 2009 Mar; 2(1):9-18.
Score: 0.222
-
Impact of in-stent restenosis on death and myocardial infarction. Am J Cardiol. 2007 Oct 01; 100(7):1109-13.
Score: 0.200
-
Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):429-37.
Score: 0.067
-
Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. Eur Heart J. 2010 May; 31(9):1079-87.
Score: 0.060
-
Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Revasc Med. 2009 Jul-Sep; 10(3):156-61.
Score: 0.057
-
Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions. Am Heart J. 2009 May; 157(5):894-8.
Score: 0.057
-
Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes. J Invasive Cardiol. 2009 May; 21(5):210-4.
Score: 0.057
-
Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
Score: 0.056
-
Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009 Mar 15; 103(6):801-5.
Score: 0.056
-
Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol. 2008 Sep 01; 102(5):530-4.
Score: 0.053
-
Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock. Am J Cardiol. 2008 Aug 01; 102(3):287-91.
Score: 0.053
-
Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics. Am J Cardiol. 2008 Feb 15; 101(4):452-6.
Score: 0.052
-
Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med. 2008 Jan-Mar; 9(1):24-8.
Score: 0.052
-
Assessing risk after acute myocardial infarction. J Am Coll Cardiol. 2007 Jun 05; 49(22):2227; author reply 2227-8.
Score: 0.050
-
Drug-eluting stent thrombosis vs bare metal stent restenosis: finding the lesser of two evils. Am Heart Hosp J. 2007; 5(3):151-4.
Score: 0.048
-
Comparison of lipid deposition at coronary bifurcations versus at nonbifurcation portions of coronary arteries as determined by near-infrared spectroscopy. Am J Cardiol. 2013 Aug 01; 112(3):369-72.
Score: 0.019
-
Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv. 2013 Feb; 81(2):348-55.
Score: 0.017
-
Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):866-70.
Score: 0.014
-
Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
Score: 0.014
-
Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol. 2008 Aug 01; 102(3):298-303.
Score: 0.013
-
Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Feb 01; 101(3):293-9.
Score: 0.013